Patience C. Ogbozor
Director/Board Member bei KID CASTLE EDUCATIONAL CORPORATION
Profil
Ms. Patience C.
Ogbozor is a President, Chief Executive Officer & Director at Cannabinoid Biosciences, Inc. She is on the Board of Directors at Opportunity Zone Capital LLC, GiveMePower Corp., Kid Castle Educational Corp., Video River Networks, Inc., Goldstein Franklin, Inc. and Cannabinoid Biosciences, Inc.
Aktive Positionen von Patience C. Ogbozor
| Unternehmen | Position | Beginn |
|---|---|---|
| KID CASTLE EDUCATIONAL CORPORATION | Director/Board Member | 23.10.2019 |
| GIVEMEPOWER CORPORATION | Director/Board Member | 01.12.2019 |
| VIDEO RIVER NETWORKS, INC. | Director/Board Member | 01.10.2019 |
Cannabinoid Biosciences, Inc.
 Cannabinoid Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Cannabinoid Biosciences, Inc. engages in the discovery, development, and commercialization of cannabinoid, cannabidiol, endocannabinoids, phytocannabinoids, and synthetic cannabinoids. It seeks to commercialize its products through collaborations with pharmaceutical companies for the specific treatments of diseases and medical conditions. The company was founded in May 2014 and is headquartered in Torrance, CA. | Chief Executive Officer | 01.11.2018 |
| Goldstein Franklin, Inc. | Director/Board Member | 01.06.2015 |
| Opportunity Zone Capital LLC | Director/Board Member | 18.02.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| KID CASTLE EDUCATIONAL CORPORATION | Commercial Services |
| GIVEMEPOWER CORPORATION | Technology Services |
| VIDEO RIVER NETWORKS, INC. | Electronic Technology |
| Private Unternehmen | 3 |
|---|---|
Cannabinoid Biosciences, Inc.
Cannabinoid Biosciences, Inc. Pharmaceuticals: OtherHealth Technology Cannabinoid Biosciences, Inc. engages in the discovery, development, and commercialization of cannabinoid, cannabidiol, endocannabinoids, phytocannabinoids, and synthetic cannabinoids. It seeks to commercialize its products through collaborations with pharmaceutical companies for the specific treatments of diseases and medical conditions. The company was founded in May 2014 and is headquartered in Torrance, CA. | Health Technology |
| Goldstein Franklin, Inc. | |
| Opportunity Zone Capital LLC |
